Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Perimeter Medical Imaging AI Inc V.PINK

Alternate Symbol(s):  PYNKF

Perimeter Medical Imaging AI, Inc. is a medical technology company driven to transform cancer surgery with resolution, real-time, imaging tools to address high unmet medical needs. It develops and commercializes in-procedural medical imaging tools. The Company’s Perimeter Optical Coherence Tomography (OCT) system, which provides cross-sectional, real-time margin visualization of tissue microstructures during surgical procedures. The Perimeter S-Series OCT is designed to provide surgeons with the clinical support they need in the OR. The OCT medical imaging system includes an intraoperative device for automated scanning of a tissue specimen that provides a rapid subsurface map of up to a 10 cm by 10 cm surface area; a specimen-handling consumable designed to hold and maintain orientation of the specimen, and an image library and training set. Its machine learning tools and artificial intelligence technology, called ImgAssist AI, through clinical development under its ATLAS AI project.


TSXV:PINK - Post by User

Comment by Sgoldenon Feb 05, 2021 12:10pm
265 Views
Post# 32484506

RE:RE:Broker Notes

RE:RE:Broker NotesHere is a good layout of the value proposition for Pink by an analyst

https://www.chimeraresearchgroup.com/2020/10/perimeter-otis-optical-coherence-tomography-and-the-future-of-ai-in-surgical-breast-cancer-treatment/

In our view, and based on the potential of OTIS successful launch starting by early 2021, targeting 30% of the total addressable US market, our base price target is C$7.00, and post launching the artificial intelligence (AI) plug-in for OTIS, ImgAssist AI our high sky price target is C$14.00"
<< Previous
Bullboard Posts
Next >>